Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 31.86
PDEX's Cash to Debt is ranked higher than
70% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. PDEX: 31.86 )
Ranked among companies with meaningful Cash to Debt only.
PDEX' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 1.31 Max: No Debt
Current: 31.86
Equity to Asset 0.80
PDEX's Equity to Asset is ranked higher than
81% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. PDEX: 0.80 )
Ranked among companies with meaningful Equity to Asset only.
PDEX' s Equity to Asset Range Over the Past 10 Years
Min: 0.24  Med: 0.7 Max: 0.87
Current: 0.8
0.24
0.87
Interest Coverage 14.22
PDEX's Interest Coverage is ranked lower than
64% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 40.78 vs. PDEX: 14.22 )
Ranked among companies with meaningful Interest Coverage only.
PDEX' s Interest Coverage Range Over the Past 10 Years
Min: 2.52  Med: 8.43 Max: 23.5
Current: 14.22
2.52
23.5
F-Score: 6
Z-Score: 7.01
M-Score: -2.67
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 2.61
PDEX's Operating margin (%) is ranked lower than
53% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.16 vs. PDEX: 2.61 )
Ranked among companies with meaningful Operating margin (%) only.
PDEX' s Operating margin (%) Range Over the Past 10 Years
Min: -15.47  Med: -6.9 Max: 14.46
Current: 2.61
-15.47
14.46
Net-margin (%) 4.08
PDEX's Net-margin (%) is ranked higher than
55% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.53 vs. PDEX: 4.08 )
Ranked among companies with meaningful Net-margin (%) only.
PDEX' s Net-margin (%) Range Over the Past 10 Years
Min: -14.56  Med: -3.62 Max: 10.97
Current: 4.08
-14.56
10.97
ROE (%) 9.43
PDEX's ROE (%) is ranked higher than
65% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.19 vs. PDEX: 9.43 )
Ranked among companies with meaningful ROE (%) only.
PDEX' s ROE (%) Range Over the Past 10 Years
Min: -32.8  Med: -4.91 Max: 29.43
Current: 9.43
-32.8
29.43
ROA (%) 6.90
PDEX's ROA (%) is ranked higher than
72% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. PDEX: 6.90 )
Ranked among companies with meaningful ROA (%) only.
PDEX' s ROA (%) Range Over the Past 10 Years
Min: -19.31  Med: -3.7 Max: 17.69
Current: 6.9
-19.31
17.69
ROC (Joel Greenblatt) (%) 14.22
PDEX's ROC (Joel Greenblatt) (%) is ranked higher than
58% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.92 vs. PDEX: 14.22 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PDEX' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -37.62  Med: -10.6 Max: 48.81
Current: 14.22
-37.62
48.81
Revenue Growth (3Y)(%) 9.40
PDEX's Revenue Growth (3Y)(%) is ranked higher than
73% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. PDEX: 9.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PDEX' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -24.9  Med: -3.4 Max: 20.9
Current: 9.4
-24.9
20.9
» PDEX's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-11-10)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with PDEX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:OTCBB:NEPH, NAS:AKER, NAS:BMRA, NAS:DXTR, NAS:BLFS, OTCPK:UEEC, OTCPK:REPR, NAS:SKLN, OTCPK:STXS, OTCPK:LDSYF, AMEX:DXR, NAS:NURO, NAS:SSKN, OTCPK:PEYE, OTCPK:IRSB, OTCPK:RSCF, OTCPK:ECIA, OTCPK:SOAN, OTCPK:ASNB, AMEX:ISR » details
Traded in other countries:PDXN.Germany,
Pro-Dex Inc with operations in designs and produces powered surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries.

Pro-Dex Inc was incorporated in the State of Colorado. The Company with operations in Irvine, California and Beaverton, Oregon, designs and produces powered surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Companys products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high-tech manufacturing operations internationally. The names Micro Motors, Oregon Micro Systems, and Astromec are used for marketing purposes as brand names. The Companys medical device products utilize under development and supply agreements and are manufactured in Irvine, California facility, as are its dental products. Its medical device products are sold mainly to original equipment manufacturers and its dental products are sold mainly to dental product distributors. In its Beaverton, Oregon facility, it designs and manufactures embedded multi-axis motion controllers which are sold to distributors or original equipment manufacturers in the automation and research industries. The Company competes in all of its markets with other medical device and motion control related companies. As a provider of outsourced services, it also competes with its customers own internal development and manufacturing groups. The manufacture and distribution of medical and dental devices are subject to state and federal requirements set forth by various agencies including state dental boards and the U.S. Food and Drug Administration.

Ratios

vs
industry
vs
history
P/E(ttm) 23.50
PDEX's P/E(ttm) is ranked higher than
60% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.50 vs. PDEX: 23.50 )
Ranked among companies with meaningful P/E(ttm) only.
PDEX' s P/E(ttm) Range Over the Past 10 Years
Min: 2.06  Med: 19.38 Max: 67.5
Current: 23.5
2.06
67.5
PE(NRI) 23.50
PDEX's PE(NRI) is ranked higher than
59% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.80 vs. PDEX: 23.50 )
Ranked among companies with meaningful PE(NRI) only.
PDEX' s PE(NRI) Range Over the Past 10 Years
Min: 2.19  Med: 19.42 Max: 67.5
Current: 23.5
2.19
67.5
Price/Owner Earnings (ttm) 54.64
PDEX's Price/Owner Earnings (ttm) is ranked lower than
81% of the 79 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.25 vs. PDEX: 54.64 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
PDEX' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 2.16  Med: 15.22 Max: 185.58
Current: 54.64
2.16
185.58
P/B 2.15
PDEX's P/B is ranked higher than
63% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.23 vs. PDEX: 2.15 )
Ranked among companies with meaningful P/B only.
PDEX' s P/B Range Over the Past 10 Years
Min: 0.27  Med: 0.94 Max: 2.99
Current: 2.15
0.27
2.99
P/S 0.97
PDEX's P/S is ranked higher than
78% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.13 vs. PDEX: 0.97 )
Ranked among companies with meaningful P/S only.
PDEX' s P/S Range Over the Past 10 Years
Min: 0.15  Med: 0.58 Max: 2.43
Current: 0.97
0.15
2.43
PFCF 151.64
PDEX's PFCF is ranked lower than
90% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.58 vs. PDEX: 151.64 )
Ranked among companies with meaningful PFCF only.
PDEX' s PFCF Range Over the Past 10 Years
Min: 1.41  Med: 4.57 Max: 202.5
Current: 151.64
1.41
202.5
POCF 41.96
PDEX's POCF is ranked lower than
86% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.69 vs. PDEX: 41.96 )
Ranked among companies with meaningful POCF only.
PDEX' s POCF Range Over the Past 10 Years
Min: 1.34  Med: 5.59 Max: 372
Current: 41.96
1.34
372
EV-to-EBIT 19.08
PDEX's EV-to-EBIT is ranked higher than
54% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.20 vs. PDEX: 19.08 )
Ranked among companies with meaningful EV-to-EBIT only.
PDEX' s EV-to-EBIT Range Over the Past 10 Years
Min: -73.1  Med: -1.8 Max: 37.1
Current: 19.08
-73.1
37.1
EV-to-EBITDA 11.24
PDEX's EV-to-EBITDA is ranked higher than
71% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.23 vs. PDEX: 11.24 )
Ranked among companies with meaningful EV-to-EBITDA only.
PDEX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.4  Med: 2 Max: 271.9
Current: 11.24
-27.4
271.9
Current Ratio 4.44
PDEX's Current Ratio is ranked higher than
79% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. PDEX: 4.44 )
Ranked among companies with meaningful Current Ratio only.
PDEX' s Current Ratio Range Over the Past 10 Years
Min: 0.7  Med: 2.93 Max: 6.04
Current: 4.44
0.7
6.04
Quick Ratio 2.72
PDEX's Quick Ratio is ranked higher than
73% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.64 vs. PDEX: 2.72 )
Ranked among companies with meaningful Quick Ratio only.
PDEX' s Quick Ratio Range Over the Past 10 Years
Min: 0.35  Med: 1.66 Max: 4.13
Current: 2.72
0.35
4.13
Days Inventory 102.58
PDEX's Days Inventory is ranked higher than
66% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.57 vs. PDEX: 102.58 )
Ranked among companies with meaningful Days Inventory only.
PDEX' s Days Inventory Range Over the Past 10 Years
Min: 81.04  Med: 106.19 Max: 149.66
Current: 102.58
81.04
149.66
Days Sales Outstanding 26.60
PDEX's Days Sales Outstanding is ranked higher than
92% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.25 vs. PDEX: 26.60 )
Ranked among companies with meaningful Days Sales Outstanding only.
PDEX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 26.6  Med: 42.82 Max: 63.44
Current: 26.6
26.6
63.44
Days Payable 20.80
PDEX's Days Payable is ranked lower than
90% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 48.01 vs. PDEX: 20.80 )
Ranked among companies with meaningful Days Payable only.
PDEX' s Days Payable Range Over the Past 10 Years
Min: 19.51  Med: 31.55 Max: 70.41
Current: 20.8
19.51
70.41

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -6.50
PDEX's 3-Year Average Share Buyback Ratio is ranked lower than
64% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.10 vs. PDEX: -6.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PDEX' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.8  Med: -0.5 Max: 0.3
Current: -6.5
-8.8
0.3

Valuation & Return

vs
industry
vs
history
Price/Net Cash 470.00
PDEX's Price/Net Cash is ranked lower than
94% of the 50 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.23 vs. PDEX: 470.00 )
Ranked among companies with meaningful Price/Net Cash only.
PDEX' s Price/Net Cash Range Over the Past 10 Years
Min: 7.81  Med: 23.08 Max: 556
Current: 470
7.81
556
Price/Net Current Asset Value 2.73
PDEX's Price/Net Current Asset Value is ranked higher than
86% of the 116 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.50 vs. PDEX: 2.73 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
PDEX' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.03  Med: 2.66 Max: 4.69
Current: 2.73
1.03
4.69
Price/Tangible Book 2.29
PDEX's Price/Tangible Book is ranked higher than
68% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.58 vs. PDEX: 2.29 )
Ranked among companies with meaningful Price/Tangible Book only.
PDEX' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.58  Med: 1.62 Max: 16.38
Current: 2.29
0.58
16.38
Price/Projected FCF 3.07
PDEX's Price/Projected FCF is ranked lower than
70% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.95 vs. PDEX: 3.07 )
Ranked among companies with meaningful Price/Projected FCF only.
PDEX' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.36  Med: 1.29 Max: 5.93
Current: 3.07
0.36
5.93
Price/Median PS Value 1.69
PDEX's Price/Median PS Value is ranked lower than
78% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.18 vs. PDEX: 1.69 )
Ranked among companies with meaningful Price/Median PS Value only.
PDEX' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.35  Med: 1.21 Max: 4.07
Current: 1.69
0.35
4.07
Price/Graham Number 1.55
PDEX's Price/Graham Number is ranked higher than
72% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. PDEX: 1.55 )
Ranked among companies with meaningful Price/Graham Number only.
PDEX' s Price/Graham Number Range Over the Past 10 Years
Min: 0.27  Med: 1.61 Max: 4.57
Current: 1.55
0.27
4.57
Earnings Yield (Greenblatt) (%) 5.17
PDEX's Earnings Yield (Greenblatt) (%) is ranked higher than
73% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. PDEX: 5.17 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PDEX' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.7  Med: 6.6 Max: 183.6
Current: 5.17
2.7
183.6
Forward Rate of Return (Yacktman) (%) -27.54
PDEX's Forward Rate of Return (Yacktman) (%) is ranked lower than
95% of the 93 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. PDEX: -27.54 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
PDEX' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -27.54  Med: 6 Max: 25
Current: -27.54
-27.54
25

More Statistics

Revenue (TTM) (Mil) $20.16
EPS (TTM) $ 0.20
Beta-0.36
Short Percentage of Float0.37%
52-Week Range $2.23 - 6.68
Shares Outstanding (Mil)4.06
» More Articles for PDEX

Headlines

Articles On GuruFocus.com
Bsquare and Pro-Dex Improved Financial Performance; Avon Products Fakes Bid May 15 2015 
Incentives matter: Pro-Dex (PDEX) Oct 10 2013 
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 
Pro-Dex Inc: Are Stories Of Its Death Greatly Exaggerated? Dec 12 2011 
ProDex Inc. Reports Operating Results (10-Q) Feb 10 2011 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 23,946 Shares Nov 06 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 15,000 Shares Nov 04 2009 
ProDex Inc. Reports Operating Results (10-K) Sep 17 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 28,000 Shares Jun 11 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 19,504 Shares Jun 04 2009 

More From Other Websites
PRO DEX INC Financials Sep 21 2016
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: 2016 By the Numbers : September 20, 2016 Sep 20 2016
Pro-Dex, Inc. Announces Fiscal 2016 Fourth Quarter and Full-Year Results Sep 15 2016
PRO DEX INC Files SEC form 8-K, Results of Operations and Financial Condition Sep 15 2016
Pro-Dex, Inc. Announces Fiscal 2016 Fourth Quarter and Full-Year Results Sep 15 2016
PRO DEX INC Files SEC form 10-K, Annual Report Sep 15 2016
PRO DEX INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 14 2016
PRO DEX INC Files SEC form 8-K, Other Events Sep 12 2016
PRO DEX INC Files SEC form 8-K, Other Events May 27 2016
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q3, 2016 By the Numbers May 19 2016
PRO DEX INC Financials May 19 2016
Pro-Dex, Inc.: Strong price momentum but will it sustain? May 16 2016
Pro-Dex, Inc. Announces Fiscal 2016 Third Quarter and Nine-Month Results May 12 2016
PRO DEX INC Files SEC form 8-K, Results of Operations and Financial Condition May 12 2016
PRO DEX INC Files SEC form 10-Q, Quarterly Report May 12 2016
Pro-Dex, Inc. Announces Fiscal 2016 Third Quarter and Nine-Month Results May 12 2016
PRO DEX INC Files SEC form 8-K, Other Events Apr 19 2016
PRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Feb 25 2016
Pro-Dex, Inc.: Strong price momentum but will it sustain? Feb 16 2016
4 Stocks That are Trading With Heavy Volume Today Feb 12 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)